Chang-yuil G. Kang
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Limited Cross-Neutralization of Emerging SARS-CoV-2 BA.3.2.2 After LP.8.1-Updated Vaccination.
Journal: Journal of medical virology
Published: March 23, 2026
Development and reproductive safety of AdCLD-CoV19, an adenoviral vector-based COVID-19 vaccine, in female Sprague-Dawley rats and their offspring.
Journal: Toxicology and applied pharmacology
Published: April 04, 2025
Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants.
Journal: Frontiers in immunology
Published: March 21, 2025
Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults.
Journal: mSphere
Published: December 26, 2024
Continuous Tracking for Effective Tackling: Ad5/35 Platform-Based JN1 Lineage Vaccines Development in Response to Evolving SARS-CoV-2 Variants.
Journal: Journal of medical virology
Published: October 19, 2024
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 26, 2024
Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
Journal: Frontiers in immunology
Published: January 16, 2024
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials.
Journal: Immune network
Published: November 15, 2023
Boosting with variant-matched adenovirus-based vaccines promotes neutralizing antibody responses against SARS-CoV-2 Omicron sublineages in mice.
Journal: International journal of antimicrobial agents
Published: August 02, 2023
Liver X receptor controls follicular helper T cell differentiation via repression of TCF-1.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 21, 2023
First-in-Human Phase 1 Study of a B Cell- and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric Cancer.
Journal: Cancer research and treatment
Published: October 02, 2022
The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates.
Journal: Vaccines
Published: April 06, 2022
Last Updated: 09/26/2026